Lung conditions are the third biggest killer in the UK. We can’t afford to slow down the search for life-saving treatments when people are still fighting for breath.
We want to see development of new drugs through the reintroduction of more clinical trials to the UK via a connected platform.
We’re calling for:
- A £4 million investment to revitalise experimental medical research and make the UK the best place for large-scale clinical trials.
- More clinical trials in the UK via a connected platform to accelerate the development of new drugs and therapeutic targets.
- A commitment to further the role of technologies such as AI, quantum computing and regenerative medicine in identifying potential treatments and therapies.